Published online by Cambridge University Press: 29 October 2024
Management of paediatric non-tuberculous mycobacteria cervicofacial lymphadenitis (NTMCL) is variable without standard practice in the U.K. We undertook a survey to evaluate current U.K. practice in tertiary paediatric units.
A survey of twenty-one tertiary paediatric centres to evaluate NTMCL management.
We received over 90% response rate. Only 21% have local guidelines, with the majority believing that written national guidance would improve management. Surgery is the most common management choice (69%), with a more limited procedure if skin is involved and/or in proximity to important structures. Observation alone is favoured (32%) when there is no skin involvement but in close proximity to the facial nerve. When treated medically, rifampicin and clarithromycin for 3 months was the commonest choice. Over 25% of respondents state their management has changed following previous adverse outcomes within their own practice or department.
This survey consolidates the current management of NTMCL in U.K. tertiary paediatric units.
Timothy Williams takes responsibility for the integrity of the content of the paper.This work was presented, through oral presentation, at the European Society of Pediatric Otorhinolaryngology congress, 21 May 2023, Liverpool, UK.